We hypothesized that MAP3K19 is involved in downstream TWEAK stimulation and airway inflammation in patients with asthma because TWEAK can activate NF-κB and enhance the TGF-β1-induced EMT [6,17,18]. The gene discussed is TGFB1; the disease is asthma.